A STUDY TO EVALUATE EFFICACY AND SAFETY OF A SINGLE APPLICATION OF CAPSAICIN 8%TRANSDERMAL DELIVERY SYSTEM COMPARED TO PLACEBO IN REDUCING PAIN INTENSITY IN SUBJECTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN):